Russell A.S., Rosenbaum J.T. Anti-tumor necrosis factor therapies in immune-mediated rheumatic diseases. Other observations from the clinic. J Rheumatol Suppl 2010, 85:53-62.
Collamer A.N., Battafarano D.F. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: Clinical features and possible immunopathogenesis. Semin Arthritis Rheum 2010, 40:233-240.
Ko J.M., Gottlieb A.B., Kerbleski J.F. Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases. J Dermatol Treat 2009, 20:100-108.
De Cid R., Riveira-Muñoz E., Zeeuwen P.L., Robarge J., Liao W., Dannhauser E.N., et al. Deletion of the late cornified envelope LCE3C and LCE3B genes as a susceptibility factor for psoriasis. Nat Genet 2009, 41:211-215.
Ikaheimo I., Tiilikainen A., Karvonen J., Silvennoinen-Kassinen S. HLA risk haplotype Cw6, DR7, DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris. Arch Dermatol Res 1996, 288:363-365.
Henseler T. Genetics of psoriasis. Arch Dermatol Res 1998, 90:463-476.
Asumalahti K., Ameen M., Suomela S., Hagforsen E., Michaëlsson G., Evans J., et al. Genetic análisis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J invest Dermatol 2003, 148:233-235.
Riviera-Muñoz E., He S.M., Escaramís G., Stuart P.E., Hüffmeier U., Lee C., et al. Meta-Analysis confirms the LCE3C LCE3B deletion as a risk factor for psoriasis in several ethnic group with HLA-Cw6. J Invest Dermatol 2011, 131:1105-1109.
Docampo E., Giardina E., Riviera-Muñoz E., de Cid R., Escaramís G., Perricone C., et al. Deletion of the LCE3C and LCE3B genes is a susceptibility factor for psoriatic arthritis: A study in Spanish and Italian populations and meta-analysis. Arthritis Rheum 2011, 63:1860-1865.
Docampo E., Rabionet R., Riviera-Muñoz E., Escaramís G., Julià A., Marsal S., et al. Deletion of the late cornified envelope genes, LCE3C and LCE3B, is associated with rheumatoid arthritis. Arthritis Rheum 2010, 62:1246-1251.
